Read news on HSP90β with our app.
Read more in the app
Targeting the 4EBP1/HSP90β/Nrf2 axis sensitizes β-catenin-mutant hepatocellular carcinoma to mTOR inhibitors via ferroptosis induction - EurekAlert!
